Although the use of this intratumoral biomarker in clinical routine has not been protocolized, analyses of FAP in different solid tumors have shown that it has great potential as a prognostic marker, generally being significantly associated with tumor aggressiveness and inferior survival [2,4,8,21,26]. This evidence concerns the gene FAP and neoplasm.